Q4 2025 Holdings
Filed 2026-02-13 | 23 holdings | $170.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $22.3M | 551,190 | 13.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $20.1M | 229,619 | 11.8% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $13.1M | 999,967 | 7.7% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $11.7M | 321,983 | 6.9% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $11.5M | 3,149,907 | 6.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $10.1M | 1,307,330 | 5.9% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $8.7M | 82,686 | 5.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.2M | 183,704 | 4.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.2M | 67,586 | 4.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.6M | 94,443 | 3.9% |
| Inventiva SA(IVA) | ADS | 46124U107 | $6.0M | 1,298,701 | 3.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.0M | 1,114,005 | 3.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.2M | 752,631 | 3.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $5.0M | 615,720 | 3.0% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $4.4M | 372,856 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.4M | 95,485 | 2.6% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $3.9M | 228,286 | 2.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.4M | 95,819 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.4M | 42,778 | 2.0% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $3.0M | 149,750 | 1.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.9M | 163,362 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.1M | 131,796 | 1.2% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $1.3M | 157,827 | 0.8% |